Beeline Medicines

United States
42 Total Employees
Year Founded: 2025
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies for people living with autoimmune and inflammatory diseases. The company leverages a mechanistically-guided approach to target the underlying drivers of immune dysfunction, aiming to define new treatment paradigms and provide durable, life-changing impact for patients suffering from a broad array of devastating immune-mediated conditions to improve patient outcomes.

Beeline Medicines Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
United States